APO TP 25
Pill imprint APO TP 25 has been identified as Topiramate 25 mg.
Topiramate is used in the treatment of migraine prevention; seizure prevention; bipolar disorder; smoking cessation; obesity (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Topiramate 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Topiramate Images
- Imprint:
-
APO
TP 25 - Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-2760
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-6016 | Major Pharmaceuticals |
Note: Inactive ingredients may vary.
Advertisement
More Topiramate resources
- Topiramate (Wolters Kluwer)
- Topiramate Sprinkle Capsules (Wolters Kluwer)
- topiramate (Cerner Multum)
- topiramate (Micromedex) - Includes Dosage Information
- Topiramate (AHFS DI)
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate (Wolters Kluwer)
Search Again
